Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Treatment and Prevention for People Who Inject Drugs: A Vanguard Study for a Network-based Randomized HIV Prevention Trial Comparing an Integrated Intervention Including Supported Antiretroviral Therapy to the Standard of Care

NCT02935296 is registered in ClinicalTrials.gov with HIV Prevention Trials Network as lead sponsor.

NCT NCT02935296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02935296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Treatment and Prevention for People Who Inject Drugs: A Vanguard Study for a Network-based Randomized HIV Prevention Trial Comparing an Integrated Intervention Including Supported Antiretroviral Therapy to the Standard of Care
Lead sponsor
HIV Prevention Trials Network
Phase
Not applicable
Overall status
Completed
Start date
February 4, 2015
Completion date
June 30, 2018
Enrollment
1,281 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv positive